The ratings of four Life Science stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Mettler-Toledo International‘s (NYSE:MTD) rating falls to a D (“sell”) this week, down from C (“hold”) the week prior. Mettler-Toledo International supplies precision instruments and services and is a provider of weighing instruments for use in laboratory, industrial and food retailing applications. For a full analysis of MTD stock, visit Portfolio Grader.
Agilent Technologies (NYSE:A) earns a D this week, falling from last week’s grade of C. Agilent Technologies serves the communications, electronics, life sciences, and chemical analysis industries by designing and producing bio-analytical and electronic measurement solutions. The stock price has fallen 6.1% over the past month, worse than the S&P 500, which has risen 1% over the same period of time. For more information, get Portfolio Grader’s complete analysis of A stock.
This week, BG Medicin‘s (NASDAQ:BGMD) rating worsens to a D from the company’s C rating a week ago. BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel diagnostic tests based on biomarkers for high-value market opportunities in healthcare that it identifies. The stock gets F’s in Equity, Cash Flow, and Sales Growth. Investors seem to agree with the downgrade and have pushed down the share price 40% over the past month. To get an in-depth look at BGMD, get Portfolio Grader’s complete analysis of BGMD stock.
This is a rough week for Compugen (NASDAQ:CGEN). The company’s rating falls to D from the previous week’s C. Compugen focuses on the therapeutic proteins and monoclonal antibodies to address unmet needs in the fields of immunology and oncology. The stock gets F’s in Equity and Cash Flow. For more information, get Portfolio Grader’s complete analysis of CGEN stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
